Michael Conner is a seasoned research scientist specializing in preclinical pharmacology and the translational development of large molecule oncology assets. They have experience in matrix team leadership throughout the various stages of early drug discovery, from target identification to IND submission. Michael has worked in notable institutions, including the University of Kansas and The Children's Hospital of Philadelphia, where they focused on areas such as hematopoietic stem cell transplantation and chromatin remodeling. Additionally, they hold a Professional Science Masters in Biotechnology from Temple University and completed a Bachelor of Science in Biochemistry from the University of Kansas.
This person is not in any teams
This person is not in any offices